S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
S&P 500   3,901.82 (+2.38%)
DOW   31,535.51 (+1.95%)
QQQ   323.59 (+3.01%)
AAPL   127.79 (+5.39%)
MSFT   236.94 (+1.96%)
FB   264.91 (+2.83%)
GOOGL   2,069.66 (+2.36%)
TSLA   718.43 (+6.36%)
AMZN   3,146.14 (+1.72%)
NVDA   553.67 (+0.93%)
BABA   241.69 (+1.65%)
CGC   34.73 (+6.05%)
GE   13.11 (+4.55%)
MU   94.76 (+3.53%)
NIO   49.76 (+8.69%)
AMD   86.39 (+2.22%)
T   28.09 (+0.72%)
F   11.98 (+2.39%)
ACB   11.04 (+4.94%)
DIS   194.98 (+3.14%)
BA   224.39 (+5.84%)
NFLX   550.64 (+2.19%)
BAC   35.79 (+3.11%)
Log in
CNSX:PREV

(PREV) Competitors

Add
Compare
Today's Range N/A
50-Day Range
$0.03
MA: $0.04
$0.06
52-Week Range N/A
Volume694,224 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

(PREV) (CNSX:PREV) Vs. CRON, TRIL, CXR, BU, APS, and TH

Should you be buying PREV stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to (PREV), including Cronos Group Inc. (CRON.TO) (CRON), Trillium Therapeutics Inc. (TRIL.TO) (TRIL), Concordia International (CXR), Burcon NutraScience Co. (BU.TO) (BU), Aptose Biosciences (APS), and Theratechnologies (TH).

(PREV) (CNSX:PREV) and Cronos Group Inc. (CRON.TO) (TSE:CRON) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations and risk.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for (PREV) and Cronos Group Inc. (CRON.TO), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
Cronos Group Inc. (CRON.TO)12202.20

Cronos Group Inc. (CRON.TO) has a consensus price target of C$8.93, indicating a potential downside of 36.09%.

Earnings & Valuation

This table compares (PREV) and Cronos Group Inc. (CRON.TO)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
Cronos Group Inc. (CRON.TO)C$36.98 million134.55C$102.23 millionC$0.2948.68

Cronos Group Inc. (CRON.TO) has higher revenue and earnings than (PREV).

Profitability

This table compares (PREV) and Cronos Group Inc. (CRON.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
Cronos Group Inc. (CRON.TO)N/AN/AN/A

Summary

Cronos Group Inc. (CRON.TO) beats (PREV) on 2 of the 2 factors compared between the two stocks.

Trillium Therapeutics Inc. (TRIL.TO) (TSE:TRIL) and (PREV) (CNSX:PREV) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

Valuation & Earnings

This table compares Trillium Therapeutics Inc. (TRIL.TO) and (PREV)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trillium Therapeutics Inc. (TRIL.TO)C$115,000.0012,969.57$-291,552,555.00C($2.90)-5.12
(PREV)N/AN/AN/AN/AN/A

(PREV) has lower revenue, but higher earnings than Trillium Therapeutics Inc. (TRIL.TO).

Analyst Recommendations

This is a summary of current ratings and recommmendations for Trillium Therapeutics Inc. (TRIL.TO) and (PREV), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Trillium Therapeutics Inc. (TRIL.TO)0000N/A
(PREV)0000N/A

Trillium Therapeutics Inc. (TRIL.TO) presently has a consensus price target of C$25.00, indicating a potential upside of 68.80%.

Profitability

This table compares Trillium Therapeutics Inc. (TRIL.TO) and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Trillium Therapeutics Inc. (TRIL.TO)N/AN/AN/A
(PREV)N/AN/AN/A

Summary

Trillium Therapeutics Inc. (TRIL.TO) beats (PREV) on 1 of the 1 factors compared between the two stocks.

Concordia International (TSE:CXR) and (PREV) (CNSX:PREV) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, analyst recommendations, earnings and risk.

Earnings and Valuation

This table compares Concordia International and (PREV)'s top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concordia InternationalC$569.62 million0.00$17.20 billionC$351.68N/A
(PREV)N/AN/AN/AN/AN/A

Concordia International has higher revenue and earnings than (PREV).

Profitability

This table compares Concordia International and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Concordia InternationalN/AN/AN/A
(PREV)N/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and target prices for Concordia International and (PREV), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Concordia International0000N/A
(PREV)0000N/A

Summary

Concordia International beats (PREV) on 1 of the 1 factors compared between the two stocks.

Burcon NutraScience Co. (BU.TO) (TSE:BU) and (PREV) (CNSX:PREV) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Profitability

This table compares Burcon NutraScience Co. (BU.TO) and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Burcon NutraScience Co. (BU.TO)N/AN/AN/A
(PREV)N/AN/AN/A

Earnings & Valuation

This table compares Burcon NutraScience Co. (BU.TO) and (PREV)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Burcon NutraScience Co. (BU.TO)C$12,045.0041,702.26$107,101.00C$0.004,690.00
(PREV)N/AN/AN/AN/AN/A

Burcon NutraScience Co. (BU.TO) has higher revenue and earnings than (PREV).

Analyst Recommendations

This is a breakdown of recent ratings for Burcon NutraScience Co. (BU.TO) and (PREV), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Burcon NutraScience Co. (BU.TO)00103.00
(PREV)0000N/A

Burcon NutraScience Co. (BU.TO) presently has a consensus target price of C$5.00, indicating a potential upside of 6.61%.

Summary

Burcon NutraScience Co. (BU.TO) beats (PREV) on 2 of the 2 factors compared between the two stocks.

Aptose Biosciences (TSE:APS) and (PREV) (CNSX:PREV) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Analyst Ratings

This is a breakdown of current recommendations for Aptose Biosciences and (PREV), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aptose Biosciences00203.00
(PREV)0000N/A

Aptose Biosciences presently has a consensus price target of C$12.00, indicating a potential upside of 134.83%.

Profitability

This table compares Aptose Biosciences and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aptose BiosciencesN/AN/AN/A
(PREV)N/AN/AN/A

Valuation and Earnings

This table compares Aptose Biosciences and (PREV)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aptose BiosciencesN/AN/AN/AC($0.65)-7.87
(PREV)N/AN/AN/AN/AN/A

Summary

Aptose Biosciences beats (PREV) on 1 of the 1 factors compared between the two stocks.

(PREV) (CNSX:PREV) and Theratechnologies (TSE:TH) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Profitability

This table compares (PREV) and Theratechnologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
TheratechnologiesN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and price targets for (PREV) and Theratechnologies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
Theratechnologies02002.00

Theratechnologies has a consensus price target of C$3.75, suggesting a potential downside of 15.16%.

Valuation & Earnings

This table compares (PREV) and Theratechnologies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
TheratechnologiesC$63.33 million6.55C$-28,715,346.00C($0.31)-14.44

(PREV) has higher earnings, but lower revenue than Theratechnologies.

Summary

Theratechnologies beats (PREV) on 1 of the 1 factors compared between the two stocks.


(PREV) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Cronos Group Inc. (CRON.TO) logo
CRON
Cronos Group Inc. (CRON.TO)
0.6$13.97flatC$4.74 billionC$36.98 million48.68Analyst Report
News Coverage
TRIL
Trillium Therapeutics Inc. (TRIL.TO)
0.9$14.81flatC$1.46 billionC$115,000.00-5.12
Concordia International logo
CXR
Concordia International
0.7N/AN/AC$1.22 billionC$569.62 million0.07High Trading Volume
BU
Burcon NutraScience Co. (BU.TO)
0.8$4.69flatC$478.74 millionC$12,045.004,690.00Gap Down
APS
Aptose Biosciences
1.3$5.11flatC$450.53 millionN/A-7.87
Theratechnologies logo
TH
Theratechnologies
0.7$4.42flatC$383.81 millionC$63.33 million-14.44Analyst Downgrade
Gap Down
BLU
BELLUS Health
0.5$5.07flatC$376.02 millionC$17,269.00-8.41
NEPT
Neptune Wellness Solutions
1.2$2.00flatC$332.64 millionC$52.78 million-1.48Gap Down
ProMetic Life Sciences logo
PLI
ProMetic Life Sciences
0.5$13.60flatC$315.66 millionC$39.91 million-0.22
IMV logo
IMV
IMV
1.0$4.47flatC$285.15 millionC$36,000.00-7.45Gap Down
MDNA
Medicenna Therapeutics Corp. (MDNA.TO)
0.5$5.13flatC$266.63 millionN/A-16.60
EMC
Emblem
0.5$1.88flat$248.31 million$5.71 million-9.89
FRX
Fennec Pharmaceuticals
0.5$9.07flatC$241.32 millionN/A-10.90Upcoming Earnings
High Trading Volume
RVX
Resverlogix Corp. (RVX.TO)
0.7$0.94flatC$215.27 millionN/A52.22Gap Up
ATE
Antibe Therapeutics
1.3$5.31flatC$188.08 millionC$9.33 million-6.75Gap Down
ONC
Oncolytics Biotech Inc. (ONC.TO)
1.2$4.23flatC$177.09 millionN/A-4.69Upcoming Earnings
Gap Down
IPA
ImmunoPrecise Antibodies Ltd. (IPA.V)
0.4$16.71flatC$123.03 millionC$16.70 million-92.83
HBP
Helix BioPharma
0.5$0.88flatC$108.67 millionN/A-16.30Gap Down
ACST
Acasti Pharma Inc. (ACST.V)
0.7$0.94flatC$88.79 millionC$81,000.0034.81Gap Down
NVH
Novoheart
0.5$0.53flatC$79.23 millionC$423,500.00-13.95
MBX
Microbix Biosystems
0.9$0.61flatC$68.95 millionC$11.64 million-11.96Gap Up
PDP
Pediapharm Inc. (PDP.V)
0.5$0.30flatC$66.36 millionC$11.16 million-4.11
SBM
Sirona Biochem
0.5$0.41flatC$58.80 millionC$71,243.00-18.64High Trading Volume
PMN
ProMIS Neurosciences
0.5$0.14flatC$39.11 millionC$2,767.00-5.87
COV
Covalon Technologies Ltd. (COV.V)
0.6$1.70flatC$37.44 millionC$25.80 million-6.30Gap Up
Emerald Health Therapeutics logo
EMH
Emerald Health Therapeutics
0.5$0.34flatC$34.02 millionC$13.02 million-0.48Gap Down
IGX
IntelGenx Technologies Corp. (IGX.V)
0.5$0.41flatC$30.87 millionC$822,000.00-5.00Gap Down
QPT
Quest PharmaTech Inc. (QPT.V)
0.8$0.19flatC$21.76 millionC$38,871.000.29Gap Up
CZO
Ceapro Inc. (CZO.V)
0.7$0.70flatC$21.65 millionC$16.14 million21.21Gap Down
NRI
Nuvo Pharmaceuticals Inc. (NRI.TO)
0.8$1.72flatC$19.59 millionC$76.09 million-2.81Gap Down
CTX
Crescita Therapeutics
0.6$0.88flatC$18.17 millionC$16.67 million125.71Gap Down
KNE
Kane Biotech Inc. (KNE.V)
0.4$0.13flatC$14.12 millionC$1.65 million-2.91Gap Up
GSD
Devonian Health Group
0.5$0.24flatC$13.96 millionC$1.65 million-4.21
PAS
Pascal Biosciences
0.6$0.11flatC$12.70 millionN/A-3.28Gap Down
NSP
Naturally Splendid Enterprises
0.6$0.08flatC$11.06 millionC$2.03 million-1.74
MPH
Medicure
0.7$1.60flatC$10.80 millionC$12.71 million-1.03Gap Up
BTI
Bioasis Technologies
0.7$0.40flatC$10.16 millionC$4.12 million36.36Gap Down
HEM
Hemostemix Inc. (HEM.V)
0.6$0.42flatC$9.07 millionN/A-2.50
ICO
iCo Therapeutics Inc. (ICO.V)
0.5$0.12flatC$7.69 millionN/A-9.58High Trading Volume
Gap Down
IBT
IBEX Technologies
0.7$0.32flatC$6.94 millionC$5.30 million7.50Gap Down
IOT
Innovotech
0.8$0.19flatC$6.52 millionC$1.04 million95.00Gap Down
BCT
BriaCell Therapeutics
0.5$4.85flatC$4.48 millionN/A-0.94High Trading Volume
Gap Down
RVV
Revive Therapeutics
0.5$0.08flatC$3.62 millionN/A-3.64High Trading Volume
Gap Down
COT
Cotinga Pharmaceuticals Inc. (COT.V)
0.5$0.04flatC$1.54 millionN/A-0.30Gap Up
PBS
Pacgen Life Science Co. (PBS.V)
0.6$0.03flatC$1.30 millionC$302,079.00-5.00Gap Down
MFS
Medifocus Inc. (MFS.V)
0.5$0.01flatC$925,000.00C$2.23 million-1.00
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
COM
138267 (COM.TO)
0.5$2.95flatC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.